Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications

Journal of Infectious Diseases

Volumn 195, Issue 8, 2007, Pages 1212-1217

  Alonso, Diego Peres ^a   Ferreira, Afonso Flávio B ^c   Ribolla, Paulo Eduardo M ^a   Santos, Isabel K F De Miranda ^b   Pires E Cruz, Maria Do Socorro ^c   De Carvalho, Fernando Aécio ^c   Abatepaulo, Antonio Roberto R ^b   Costa, Dorcas Lamounier ^c   Werneck, Guilherme L ^d   Farias, Teresinha J C ^c   Soares, Maria José S ^c   Costa, Carlos Henrique N ^c,e  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e Instituto de Doencas Tropicais Natan Portella   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MANNAN BINDING LECTIN;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE COURSE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION COMPLICATION; INFECTION SENSITIVITY; LEISHMANIA CHAGASI; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HUMANS; INFANT; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; STATISTICS;

EID: 34047223686     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/512683     Document Type: Article

References (36)

1. Barbara MD, Herwaldt L. Leishmaniasis. Lancet 1999; 354:1191-9.
2. Badaró R, Jones TC, Lorenço R, et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986; 154:639-49.
3. Alvar J. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol Today 1994; 10:160-3.
4. Peacock CS, Collins A, Shaw MA, et al. Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol 2001; 20:383-96.
5. Peacock CS, Sanjeevi CB, Shaw MA, et al. Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: no major role for class II or class III regions of HLA. Genes Immun 2002; 3:350-8.
6. Karplus TM, Jeronimo SM, Chang H, et al. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 2002; 70:6919-25.
7. Mohamed HS, Ibrahim ME, Miller EN, et al. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in the Sudan. Eur J Hum Genet 2004; 12:66-74.
8. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77:171-92.
9. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7:85-94.
10. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994; 21:125-31.
11. Green PJ, Feizi T, Stoll MS, Thiel S, Prescott A, McConville MJ. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Mol Biochem Parasitol 1994; 66:319-28.
12. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155:3013-20.
13. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995; 85: 660-7.
14. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989; 2:1236-9.
15. van de Wetering JK, van Golde LM, Batenburg JJ. Collectins: players of the innate immune system. Eur J Biochem 2004; 271:1229-49.
16. Madsen HO, Satz L, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998; 161:3169-75.
17. Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999; 353:1049-53.
18. Garred P, Nielsen MA, Kurtzhals JA, et al. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun 2003; 71: 5245-53.
19. Hoal-van Helden E, Epstein J, Victor TC, et al. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 1999; 45:459-64.
20. de Miranda Santos IKF, Costa CHN, Krieger H, et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 2001; 69:5212-5.
21. Costa CH, Pereira HF, MV Araújo. Epidemia de leishmaniose visceral no Estado de Piauí, Brasil, 1980-1986. Rev Saude Publica 1990; 24: 361-72.
22. Arpini-Sampaio Z, Costa MCB, Melo AA, Carvalho MFVA, Deus MSM, Simões AA. Genetic polymorphisms and ethnic admixture in African-derived black communities of northeastern Brazil. Human Biol 1999; 71:69-85.
23. Costa CH, Werneck GL, Rodrigues L Jr, et al. Household structure and urban services: neglected targets in the control of visceral leishmaniasis. Ann Trop Med Parasitol 2005; 99:229-36.
24. Costa CH, Gomes RB, Silva MR, et al. Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis 2000; 182:997-1000.
25. Gordon AC, Waheed U, Hansen TK, et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock 2006; 25:88-93.
26. Barral-Netto M, Badaró R, Barral A, et al. Tumor necrosis factor (cachectin) in visceral leishmaniasis. J Infect Dis 1991; 163:853-7.
27. van der Poll T, Zijlstra EE, Mevissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin Immunol Immunopathol 1995; 77:111-4.
28. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998; 18:555-9.
29. Corradin SB, Buchmuller-Rouiller Y, Mauel J. Phagocytosis enhances murine macrophage activation by interpheron-gamma and tumor necrosis factor. Eur J Immunol 1991; 21:2553-8.
30. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113:1271-6.
31. Buchetont B, El-Safi SH, Hammad A, et al. Antileishmanial antibodies in an outbreak of visceral leishmaniasis in eastern Sudan: high antibody responses occur in resistant subjects and are not predictive of disease. Trans R Soc Trop Med Hyg 2003; 97:463-8.
32. Mansour MK, Latz E, Levitz SM. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J Immunol 2006; 176:3053-61.
33. Ritter U, Meissner A, Scheidig C, Korner H. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 2004; 34:1542-50.
34. Caparros E, Serrano D, Puig-Kroger A, Riol L, et al. Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes. Immunobiology 2005; 210:185-93.
35. Spear GT, Zariffard MR, Xin I, Saifuddin M. Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin. Immunology 2003; 110:80-5.
36. Fraser DA, Bohlson SS, Jasinskiene N, et al. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 2006; 80:107-16.